Revision history of "Boosting immunotherapy against lung cancer by modulating innate tumor response" (Q3161032)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

11 October 2024

  • curprev 09:3209:32, 11 October 2024DG Regio talk contribs 73,243 bytes +16 Changed label, description and/or aliases in pt
  • curprev 09:3209:32, 11 October 2024DG Regio talk contribs 73,227 bytes +24 Set a claim value: summary (P836): A imunoterapia anticorpo-baseada contra PD-1 e seus ligantes conduziu a uma mudança de paradigma no tratamento do cancro do pulmão, a causa principal da morte do cancro. No entanto, a sua eficácia parece ser limitada pela presença de um microambiente tumoral imunossupressor. Estudos anteriores da nossa equipa mostram que o imunomodulador C5a em cascata do complemento, através do seu recetor C5aR1, contribui para a formação de um microambiente imunos...

7 March 2024

20 December 2023

12 June 2023

10 June 2023

18 August 2022

  • curprev 00:4600:46, 18 August 2022DG Regio talk contribs 71,931 bytes +49,090 Changed label, description and/or aliases in el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl, nl, fr, de, it, es, and other parts: Adding translations: el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl,

16 January 2022

17 December 2021

9 December 2021

4 December 2021

12 October 2021

  • curprev 16:3516:35, 12 October 2021DG Regio talk contribs 12,520 bytes +2,303 Created claim: summary (P836): Antibody-based immunotherapy against PD-1 and its ligands has led to a paradigm shift in the treatment of lung cancer, the leading cause of cancer death. However, its effectiveness appears to be limited by the presence of an immunosuppressive tumor microenvironment. Previous studies by our team show that the complement cascade C5a immunomodulator, through its C5aR1 receptor, contributes to the formation of an immunosuppressive microenvironment f...
  • curprev 16:3516:35, 12 October 2021DG Regio talk contribs 10,217 bytes −2,303 Removed claim: summary (P836): Antibody-based immunotherapy against PD-1 and its ligands has led to a paradigm shift in the treatment of lung cancer, the leading cause of cancer death. However, its effectiveness appears to be limited by the presence of an immunosuppressive tumor microenvironment. Previous studies by our team show that the complement cascade C5a immunomodulator, through its C5aR1 receptor, contributes to the formation of an immunosuppressive microenvironment...
  • curprev 16:2016:20, 12 October 2021DG Regio talk contribs 12,520 bytes +137 Changed label, description and/or aliases in en: translated_label
  • curprev 16:2016:20, 12 October 2021DG Regio talk contribs 12,383 bytes +2,303 Created claim: summary (P836): Antibody-based immunotherapy against PD-1 and its ligands has led to a paradigm shift in the treatment of lung cancer, the leading cause of cancer death. However, its effectiveness appears to be limited by the presence of an immunosuppressive tumor microenvironment. Previous studies by our team show that the complement cascade C5a immunomodulator, through its C5aR1 receptor, contributes to the formation of an immunosuppressive microenvironment f...

10 October 2021

9 October 2021

8 October 2021